Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WuXi Diagnostics operates an integrated diagnostic enabling platform combining multiomics data from multidisciplinary technologies with advanced algorithms. Its core product line—Enabling Solution Package (ESP)—covers the full spectrum of disease management from screening to prognosis. The company has established international collaborations including an R&D center at Mayo Clinic headquarters in the US. It has received significant investment ($150M Series B) to accelerate its global market penetration. The business model emphasizes "license in + license out" partnerships to empower healthcare innovators worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WuXi Diagnostics.